Our findings unveil the manipulated expression of adipocyte PGC-1α as a novel strategy with potential therapeutic impact to improve obesity-linked cardiometabolic diseases (Figure 10). This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.